Pneumococcal conjugate second or third-dose vaccines (PCVc) in Guyana
Guyana: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 99.0% in 2025. ▲ Rising
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Guyana, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Guyana is 99.0%, measured in 2025. That is the highest value across all 18 years on record.
The figure is up 1.0% on the previous year and up 5.3% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Guyana peaked at 99.0% in 2021 and was at its lowest, 0.0%, in 2008.
Guyana ranks 1st of 194 countries on this measure, in the top 10%.
The long-run direction has been consistently rising across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Guyana, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 50.0% | — |
| 2012 | 90.0% | +80.0% |
| 2013 | 96.0% | +6.7% |
| 2014 | 97.0% | +1.0% |
| 2015 | 94.0% | -3.1% |
| 2016 | 92.0% | -2.1% |
| 2017 | 97.0% | +5.4% |
| 2018 | 91.0% | -6.2% |
| 2019 | 98.0% | +7.7% |
| 2020 | 89.0% | -9.2% |
| 2021 | 99.0% | +11.2% |
| 2022 | 95.0% | -4.0% |
| 2023 | 97.0% | +2.1% |
| 2024 | 98.0% | +1.0% |
| 2025 | 99.0% | +1.0% |
Guyana compared with similar countries
- Guyana's 99.0% is above the median for high income countries, which is 91.0%, 1.1× the median. (63 countries reporting)
- Guyana's 99.0% is above the median for Latin America & Caribbean, which is 82.5%, 1.2× the median. (32 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Guyana changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2012 | +80.0% | 50.0% | 90.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 80.5% | 0.0% | 98.0% | 10 |
| 2020s | 96.2% | 89.0% | 99.0% | 6 |
Countries ranked near Guyana
More health data for Guyana
- Un projection of annual infant deaths, annual growth rate -1.59 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4509 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,225 deaths per 1,000 people (2090)
- Number of infants who die before age 1 62 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -1.39 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0477 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.38 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Guyana?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Guyana was 99.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Guyana?
- The highest recorded value was 99.0% in 2021.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Guyana?
- The lowest recorded value was 0.0% in 2008.
- How does Guyana rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Guyana ranks 1st out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Guyana?
- Over the last ten years it is up 5.3%. The long-run trend across the full record is rising.
- Where does this Guyana data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).